Exome sequencing contributes to identify comorbidities in a rare case of infant ARDS induced by the CD40LG mutation

Xue Gong1, Yunru He1, Guoyan Lu1

  • 1Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, No. 20, 3rd Section, South Renmin Road, Chengdu, 610041, Sichuan, China.

Insights

Early exome sequencing diagnosed X-linked hyper IgM syndrome (XHIGM) in an infant with unexplained respiratory distress. This rare genetic immunodeficiency diagnosis, even with normal immunoglobulin levels, highlights the importance of genetic testing in infants with severe infections.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Genetics
  • Immunology

Background:

  • Acute respiratory distress syndrome (ARDS) presents a significant mortality risk in infants with specific diseases.
  • Early diagnosis and intervention are crucial for reducing infant mortality associated with ARDS.
  • This report details a rare case utilizing exome sequencing for the early diagnosis of immunodeficiency in an infant.

Observation:

  • A four-month-old infant presented with severe respiratory distress, hypoxemia, and unexplained lung lesions.
  • Initial viral testing was largely negative, with only rhinovirus detected.
  • Family history revealed a deceased sibling due to severe infection, prompting genetic investigation.

Findings:

  • Exome sequencing identified a CD40LG mutation, diagnosing X-linked hyper IgM syndrome (XHIGM).
  • The infant had normal plasma immunoglobulin levels, atypical for XHIGM, underscoring the diagnostic challenge.
  • Treatment with intravenous immunoglobulin (IVIG) led to clinical improvement and enhanced lung CT scans.

Implications:

  • Exome sequencing is vital for diagnosing immunodeficiencies in infants with unexplained infections, especially with a positive family history.
  • Genetic testing can identify XHIGM even when plasma immunoglobulin levels are normal, masking typical presentation.
  • This case represents the youngest infant diagnosed with molecularly confirmed XHIGM, advancing early detection strategies.
Abstract